Expression of eosinophil-specific chemokines by human epithelial cells

Chemical Immunology

Volumn 76, Issue , 2000, Pages 156-176

  Stellato, Cristiana ^a   Beck, Lisa A ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; EOTAXIN; GLUCOCORTICOID; RANTES;

ALLERGIC ASTHMA; ANGIOGENESIS; ASTHMA; CELL SURVIVAL; EFFECTOR CELL; EOSINOPHIL; EPITHELIUM CELL; HUMAN; IMMUNOMODULATION; LEUKOCYTE ACTIVATION; NONHUMAN; NOSE POLYP; PRIORITY JOURNAL; REVIEW; RHINITIS; VIRUS INFECTION;

EID: 0034098537     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058785     Document Type: Review

References (25)

1. Sur S, Adolphson CR, Gleich GJ: Eosinophils: Biochemical and cellular aspects; in Middleton E, Reed CE, Ellis EF, Adkinson NF, Jr., Yunginger JW, Busse W (eds): Allergy Principles and Practice, ed 4. St Louis, Mosby, 1993, pp 169-200.
2. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB: Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
3. Corrigan CJ, Kay AB: T-cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13:501-507.
4. Gundel RH, Letts LG, Gleich GJ: Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991;87:1470-1473.
5. Butcher EC: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
6. Bochner BS, Ebisawa M, Knol EF, Yamada T, Georas SN, Liu MC, Schleimer RP: Mechanisms of eosinophil accumulation during allergic inflammation; in Nadel J, Pozzi E, Venge P (eds): Eosinophils and Bronchial Smooth Muscle Cells. Milan, Masson Italia, 1995, pp 81-95.
7. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568.
8. Luster AD: Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-445.
9. Nickel R, Beck L, Stellato C, Schleimer R: Chemokines and allergic disease. J Allergy Clin Immunol 1999;104:723-742.
10. Premack BA, Schall TJ: Chemokine receptors: Gateways to inflammation and infection. Nat Med 1996;2:1174-1178.
11. Wells TNC, Power CA, Proudfoot AEI: Definition, function and pathophysiological significance of chemokine receptors. Trends Pharmacol Sci 1998;19:376-380.
12. Kelner GS, Kennedy J, Bacon KB, Kleyensteubcr S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A: Lymphotactin: A cytokine that represents a new class of chcmokine. Science 1994;266:1395-1399.
13. Bazan JF, Bacon KB, Hardlman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ: A new class of membrane-bound chemokine with a CX3C motif. Nature 1997;385:640-644.
14. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM: Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176:587-592.
15. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA: RANTES and macrophage inflammatory protein la induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:1489-1495.
16. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, Minty A, Baggiolini M: Monocyte chemotactic protein 3 is a most effectivc basophil- and eosinophil-activating chemokine. J Exp Med 1994;179:751-756.
17. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD: Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 1996;2:334-348.
18. Garcia-Zepeda EA, Combadiere C, Rothenberg ME, Sarafi MN, Lavigne F, Hamid Q, Murphy PM, Luster AD: Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996;157: 5613-5626.
19. Stellato C, Collins P, Li H, White J, Ponath PD, Newman W, Soler D, Bickel C, Liu M, Bochner B, Williams T, Schleimer R: Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997;99:926-936.
20. Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, Baggiolini M: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997;185:2171-2176.
21. Lee SC, Brummet ME, Woodworth T, Leiferman KM, S.Gilman, Gladue R, Schleimer RP, Beck LA: Cutaneous injection of human subjects with macrophage inflammatory protein-1α (MIP-1α) causes significant leukocyte recruitment. J Allergy Clin Immunol 1998;101:A821.
22. Bochner BS, Bickel CA, Taylor ML, MacGlashan DW Jr, Gray PW, Raport CJ, Rodiska R: Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chcmokine receptor 3- and CC chemokine receptor 4-independent manner. J Allergy Clin Immunol 1999;103:527-532.
23. Baggiolini M, Deward B, Walz A: Interleukin-8 and related chemotactic cytokines; in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press, 1992, pp 247-263.
24. Wells TN, Power CA, Lusti-Narasimhan M, Hoogewerf AJ, Cooke RM, Chung C-W, Peitsch MC, Proudfoot AEI: Selectivity and antagonism of chemokine receptors. J Leuk Biol 1996;59:53-60.
25. Murphy PM: Chemokine receptors: Structure, function and role in microbial pathogenesis. Cytokine Growth Factors Rev 1996;7:47-66.